Public Health - Drug Manufacturer-Funded Disease Awareness Campaigns - Registration and Required Disclosure

HB 1133 requires drug manufacturers and patient advocacy groups receiving drug manufacturer funding to register with Maryland's Department of Health before running disease awareness campaigns. It mandates that campaign materials disclose if the campaign relates to a drug or device the manufacturer is developing, manufacturing, or marketing. The law directly affects drug companies and patient advocacy organizations that receive manufacturer funding for campaigns focused on specific medical conditions. Campaigns promoting marketed drugs must include a clear statement identifying the specific drug or device being promoted. The bill takes effect October 1, 2026.